DB15390Investigational
Efizonerimod alfa is under investigation in clinical trial NCT02221960 (A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors).
- Also known as
- Efizonerimod
- Code names
- MEDI6383
Resolves to
Compound
What you can answer from here — as of October 30, 2025
Which companies are running trials of Efizonerimod alfa, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account